News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Why these 4 ASX cannabis stocks got investors’ attention today
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Market highlights and 5 ASX small caps to watch on Thursday
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
Cann Group lowers guidance, makes acquisition; Zelira to get new boss
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
Zelira shares soar after expanding US medical pot distribution
News
10 at 10: These ASX stocks are floating up this morning
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
News
ScoPo’s powerplays: ‘Santa is smiling on the markets’
News
Last Orders: What you might have missed on the ASX today
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
Health & Biotech
Dimerix to progress DMX-200 to phase 3 trial to treat kidney disease FSGS
Health & Biotech
Dr Boreham’s Crucible: Is Suda back on track after securing first TGA approval?
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
Aussie cannabis industry set for painful shakeup – report
Experts